Type : Classe de contamination : Durée de l’intervention :
Antibioprophylaxie : Oui Non Délai d’injection
Famille d’ATB : Molécule :
Posologie : Voie d’administration :
[1]. System, N.N.I.S., National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control, 2004. 32: p. 470-485.
[2]. Mangram, A.J., et al., Guideline for prevention of surgical site infection, 1999. Infection Control & Hospital Epidemiology, 1999. 20(4): p. 247-280.
[3].
https://www.hpci.ch/prevention/bases-theoriques/sp%C3%A9cialit%C3%A9s/antibioprophylaxie-en-chirurgie. 2019. [4]. Leblanc, P.-E., et al., Infections postopératoires en neurochirurgie. 2010, MAPAR. [5]. Altemeier, W.A., W.R. Culbertson, and M. Vetto, Prophylactic antibiotic therapy.
AMA archives of surgery, 1955. 71(1): p. 2-6.
[6]. Burke, J.F., The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery, 1961. 50(1): p. 161-168.
[7]. Bantz, P. and C. Martin. Principes généraux régissant l'antibioprophylaxie en chirurgie. in Annales françaises d'anesthésie et de réanimation. 1992. Elsevier.
[8]. Bollaert, P. and P. Canton. Antibiothérapie prophylactique en chirurgie. in Annales françaises d'anesthésie et de réanimation. 1986. Elsevier.
[9]. Otteni, J., J. Desmonts, and J. Haberer. Recommandations françaises et étrangères sur la pratique de l’anesthésie-réanimation. in Annales francaises d'anesthesie et de reanimation. 2001. Elsevier.
[10]. Minodier, P., Principes de l’antibioprophylaxie. Archives de Pédiatrie, 2013. 20: p. S57-S60.
[11]. Vachon, F., Méthodologie pratique pour l'usage rationnel de l'antibiothérapie à visée préventive (dite aussi prophylactique) en chirurgie. Médecine et Maladies Infectieuses, 1984. 14(12): p. 695-703.
[12]. Prtak, L.E. and E.J. Ridgway, Prophylactic antibiotics in surgery. Surgery (Oxford), 2009. 27(10): p. 431-434.
[13]. Courtney Ierano, J.-A.M.N., Karin Thursdayky, Surgical antimicrobial prophylaxis. Austr. Prescriber, 2017. 40(6): p. 225-229.
[14]. Berríos-Torres SI, U.C., Bratzler DW, Leas B, Stone EC, Kelz RR, et al. , Healthcare Infection Control Practices Advisory Committee Centers for Disease Control and Prevention guideline for the prevention of surgical site infection. JAMA Surg, 2017. 152: p. 784-91.
[15]. Revelas, A., Healthcare – associated infections: A public health problem. Nigerian Medical Journal 2012. 53(2): p. 59-64.
[16]. Grohskopf LA, S.-C.R., Garrett DO, Sohn AH, Levine GL, Siegel JD, et al., A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr., 2002. 140: p. 432–8.
[17]. Horan, T.C., M. Andrus, and M.A. Dudeck, CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting. American journal of infection control, 2008. 36(5): p. 309-332.
[18]. Weber WP, Z.M., Reck S, Feder-Mengus C, Misteli H, Rosenthal R, et al, Economic burden of surgical site infections at a European university hospital. Infect Control Hosp Epidemiol., 2008. 29(7): p. 623-9.
[19]. Suetens, C., et al., ECDC surveillance report: point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals, 2011–2012. Stockholm: European Centre for Disease Prevention and Control, 2013.
[20]. Anderson DJ, K.K., Classen D, Arias KM, Podgorny K, Burstin H, et al. , Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol, 2008. 29 Suppl 1: p. S51-61.
[21]. Anderson, D.J., et al., Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infection Control & Hospital Epidemiology, 2014. 35(S2): p. S66-S88.
[22]. Dechoux, C., Antibioprophylaxie et infections du site opératoire: applications et évaluation des mesures mises en place dans un hôpital de gynéco-obstétrique. 2007, UHP-Université Henri Poincaré.
[23]. C Trivalle, C.C., Antibiothérapie préventive, Editions techniques. Encycl. Med. Chir. (Paris), Thérapeutique, , 1994. 25-005-H-1 0.
[24]. Altemeler w-a., B.j.-f., Pruitt b-a., Pandusky w-r., Manual on control of infection in surgical patients. LIPPINCOTT (éd.), 1984: p. 19-30.
[25]. Owens, W.D., J.A. Felts, and J.E. Spitznagel, ASA physical status classifications: a study of consistency of ratings. Anesthesiology, 1978. 49(4): p. 239-243.
[26]. Culver, D.H., et al., Surgical wound infection rates by wound class, operative procedure, and patient risk index. The American journal of medicine, 1991. 91(3): p. S152-S157. [27]. Morales, C.H., et al., Surgical site infection in abdominal trauma patients: risk
prediction and performance of the NNIS and SENIC indexes. Canadian journal of Surgery, 2011. 54(1): p. 17.
[28]. MARTIN c., A., BARON D.. CHASSIGNOL J-F., Antibioprophylaxie en milieu chirurgical. Ann. Fr. Anesth. Réanim, 1993. 11,337-54.
[29]. MINAMI S., Y.A.I.M., MUSAHASHI S, Induction of betalactamase by various antibiotics in enterobacter C!oacae. Antimicrob. Agents Chemother.. 1980. 18: p. 399-405.
[30]. Kernodle, D.S., N.L. Barg, and A.B. Kaiser, Low-level colonization of hospitalized patients with methicillin-resistant coagulase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrobial agents and chemotherapy, 1988. 32(2): p. 202-208.
[31]. Bergamini, T.M. and H.C. Polk Jr, The importance of tissue antibiotic activity in the prevention of operative wound infection. Journal of Antimicrobial Chemotherapy, 1989. 23(3): p. 301-313.
[32]. Wittmann, D. Antibiotic concentrations in tissue fluid during the vulnerable period as a rational basis for prophylaxis of postoperative infections: focus on infections after operations of the colon, biliary tree and bone. in Recent Advances in Chemotherapy. Antimicrobial Section. 1985.
[33]. Shapiro, M., et al., Risk factors for infection at the operative site after abdominal or vaginal hysterectomy. New England Journal of Medicine, 1982. 307(27): p. 1661-1666. [34]. DICTIONNAIRE VIDAL. Ed. du Vidal, 2004. 81ème édition.
[35]. Martin, C., et al., Pharmacokinetics and tissue penetration of a single dose of ornidazole (1,000 milligrams intravenously) for antibiotic prophylaxis in colorectal surgery. Antimicrobial agents and chemotherapy, 1990. 34(10): p. 1921-1924.
[36]. Drugeon, H. Critères microbiologiques du choix d'un antibiotique pour l'antibioprophylaxie en chirurgie. in Annales françaises d'anesthésie et de réanimation. 1994. Elsevier.
[37]. Vincent.J, C.G., Pharmacologie des anti-infectieux : généralités sur les relations pharmacocinétique-pharmacodynamie. Pharmacologie des Anti-Infectieux, 2018: p. 3-7. [38]. Martin, C., et al., Règles de prescription d'une antibioprophylaxie chirurgicale.
Hygiènes (Lyon), 1997(4): p. 191-200.
[39]. Pavan, M.M. and D.L. Malyuk, A cost effective approach to surgical antibiotic prophylaxis. The Canadian journal of hospital pharmacy, 2018. 45(4).
[40]. Alexander, J.W. and N.S. Alexander, The influence of route of administration on wound fluid concentration of prophylactic antibiotics. The Journal of trauma, 1976. 16(6): p. 488-495.
[41]. MARTIN c.. VIVIAND X., P.F., Antibioprophylaxie par voie locale en chirurgie. Hygiène, 1997. 04: p. 224-230.
[42]. Classen, D.C., et al., The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. New England Journal of Medicine, 1992. 326(5): p. 281-286. [43]. Varacallo., M.F.C.M., Preoperative Antibiotic Prophylaxis. StatPearls, 2019.
[44]. Paul M, P.E., Raz A, et al. , Duration of antibiotic prophylaxis for cardiac surgery: prospective observational study. J Infect., 2009: p. 58: 291–8
[45]. C., A.L.G., Antibiothérapie de première intention en réanimation post-opératoire. Congrès National d'Anesthésie et Réanimation. Conférences d'actualisation. Paris, 1989. [46]. Alkatheri AM, A.A., Alharbi S, et al., Investigation of the effectiveness of antibacterial
prophylaxis in renal transplant recipients. J Infect Dev Ctries, 2014. 8: p. 1244–51
[47]. Harbarth, S., et al., Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation, 2000. 101(25): p. 2916-2921.
[48]. Harrington, G., et al., Surgical-site infection rates and risk factor analysis in coronary artery bypass graft surgery. Infection Control & Hospital Epidemiology, 2004. 25(6): p. 472-476.
[49]. Smith, R.L., et al., Wound infection after elective colorectal resection. Annals of surgery, 2004. 239(5): p. 599.
[50]. Pessaux, P., et al., Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Archives of Surgery, 2003. 138(3): p. 314-324.
[51]. Anaya, D.A. and E.P. Dellinger, The obese surgical patient: a susceptible host for infection. Surgical infections, 2006. 7(5): p. 473-480.
[52]. Zelenitsky, S.A., et al., Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrobial agents and chemotherapy, 2002. 46(9): p. 3026-3030.
[53]. Brill, M.J., et al., Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. Journal of Antimicrobial Chemotherapy, 2013. 69(3): p. 715-723.
[54]. Pai, M.P. and D.T. Bearden, Antimicrobial dosing considerations in obese adult patients: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007. 27(8): p. 1081-1091. [55]. Ho, V.P., et al., Cefazolin dosing for surgical prophylaxis in morbidly obese patients.
Surgical infections, 2012. 13(1): p. 33-37.
[56]. Senn.L et al, Empfehlungen zur perioperativen antibiotikaprophylaxe. Swissnoso Bulletin, 2000. 7(2): p. 9-12.
[57]. Bratzler DW, D.E., Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al., Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt), 2013. 14(1):: p. 73-156.
[58]. ANAES, Evaluation des pratiques professionnelles dans les établissements de santé-Evaluation de l'antibioprophylaxie en chirurgie propre: application à la prothèse totale de hanche. 2000: p. 3-47.
[59]. Blech, M.F., Impact de l'antibioprophylaxie sur l'écologie microbienne. . Annales Françaises d'Anesthésie et de Réanimation, 1994: p. p. S45-S50.
[60]. DiPiro, J.T., The prophylactic use of antimicrobials in surgery. Current Problems in surgery, 1983: p. 20(2): p. 69-132.
[62]. Nelson RL, G.A., Song F, Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev, 2009. CD001181.
[63]. Wong A, L.S., Nathan NS, et al., Postoperative Prophylactic Antibiotic Use following Ventral Hernia Repair with Placement of Surgical Drains Reduces the Postoperative Surgical-Site Infection Rate. Plast Reconstr Surg, 2016: p. 137: 285–94.
[64]. Elie Sader, J.M., Anna M. Cervantes-Arslanian, Neurosurgical Infections. Semin Neurol 2019. 39: p. 507–514.
[65]. O’Horo JC, S.P., Infections in neurocritical care. Neurocrit Care, 2017. 27(03): p. 458– 467.
[66]. Ramanan M, L.J., Shorr A, Shankar A, A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections. BMC Infect Dis 2015. 15:3.
[67]. van de Beek D, D.J., Tunkel AR., Nosocomial bacterial meningitis. . N Engl J Med, 2010. 362(02): p. 146–154.
[68]. Kołpa, M., et al., Epidemiology of Surgical Site Infections and Non-Surgical Infections in Neurosurgical Polish Patients—Substantial Changes in 2003–2017. International journal of environmental research and public health, 2019. 16(6): p. 911.
[69]. Iacob G, I.S., Cojocaru I., Prophylactic antibiotics in neurosurgery. Rev Med Chir Soc Med Nat Iasi., 2007. 111(3): p. 643-8.
[70]. Uzuka, T., et al., Surgical site infection after malignant brain tumor resection: a multicenter study for induction of a basic care bundle. Neurologia medico-chirurgica, 2017. 57(10): p. 542.
[71]. Patel, S., et al., Risk factors for surgical site infections in neurosurgery. The Annals of The Royal College of Surgeons of England, 2019. 101(3): p. 220-225.
[72]. Meng, F., J. Cao, and X. Meng, Risk factors for surgical site infections following spinal surgery. Journal of Clinical Neuroscience, 2015. 22(12): p. 1862-1866.
[73]. Cronquist, A.B., et al., Relationship between skin microbial counts and surgical site infection after neurosurgery. Clinical infectious diseases, 2001. 33(8): p. 1302-1308. [74]. Karhade, A.V., et al., Neurosurgical infection rates and risk factors: a National Surgical
Quality Improvement Program analysis of 132,000 patients, 2006–2014. World neurosurgery, 2017. 97: p. 205-212.
[75]. Wang, A.S., E.J. Armstrong, and A.W. Armstrong, Corticosteroids and wound healing: clinical considerations in the perioperative period. The American journal of surgery, 2013. 206(3): p. 410-417.
[76]. Cao, Y., et al., The role of antibiotic prophylaxis in clean neurosurgery. World neurosurgery, 2017. 100: p. 305-310.
[77]. Harrop, J.S., et al., Contributing factors to surgical site infections. JAAOS-Journal of the American Academy of Orthopaedic Surgeons, 2012. 20(2): p. 94-101.
[78]. Glassman, S., et al., Predictors of Hospital Readmission and Surgical Site Infection in the United States, Denmark, and Japan. Spine, 2017. 42(17): p. 1311-1315.
[79]. Davies, B.M., A. Jones, and H.C. Patel, Implementation of a care bundle and evaluation of risk factors for surgical site infection in cranial neurosurgery. Clinical neurology and neurosurgery, 2016. 144: p. 121-125.
[80]. SFAR, Antibioprophylaxie en chirurgie et médecine interventionnelle.(patients adultes): Actualisation de recommandations. 2018.
[81]. Fang, C., et al., Risk factors of neurosurgical site infection after craniotomy: a systematic review and meta-analysis. American journal of infection control, 2017. 45(11): p. e123-e134.
[82]. Abu Hamdeh, S., B. Lytsy, and E. Ronne-Engström, Surgical site infections in standard neurosurgery procedures–a study of incidence, impact and potential risk factors. British Journal of Neurosurgery, 2014. 28(2): p. 270-275.
[83]. https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/craniotomy, 2020. [84]. Maesawa, S., et al., Application of Awake Surgery for Epilepsy in Clinical Practice.
Neurologia medico-chirurgica, 2018. 58(10): p. 442.
[85]. https://www.vidanthealth.com/Services-Treatments/Treatments/Decompressive-Craniectomy, 2020.
[86]. Al-Dorzi, H.M., et al., Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection. Neurosciences, 2017. 22(2): p. 107.
[87]. O'Keeffe, A.B., T. Lawrence, and S. Bojanic, Oxford craniotomy infections database: a cost analysis of craniotomy infection. British journal of neurosurgery, 2012. 26(2): p. 265-269.
[88]. Abode-Iyamah, K.O., et al., Risk factors for surgical site infections and assessment of vancomycin powder as a preventive measure in patients undergoing first-time cranioplasty. Journal of neurosurgery, 2018. 128(4): p. 1241-1249.
[89]. Erman, T., et al., Risk factors for surgical site infections in neurosurgery patients with antibiotic prophylaxis. Surgical neurology, 2005. 63(2): p. 107-113.
[90]. Sneh-Arbib, O., et al., Surgical site infections following craniotomy focusing on possible post-operative acquisition of infection: prospective cohort study. European journal of clinical microbiology & infectious diseases, 2013. 32(12): p. 1511-1516.
[91]. Shi, Z.-H., et al., Post-craniotomy intracranial infection in patients with brain tumors: a retrospective analysis of 5723 consecutive patients. British journal of neurosurgery, 2017. 31(1): p. 5-9.
[92]. Jiménez-Martínez, E., et al., Risk factors for surgical site infection after craniotomy: a prospective cohort study. Antimicrobial Resistance & Infection Control, 2019. 8(1): p. 69. [93]. Sharma, S.B. and J.-S. Kim, A Review of Minimally Invasive Surgical Techniques for
the Management of Thoracic Disc Herniations. Neurospine, 2019. 16(1): p. 24.
[94]. Huang, R., et al. Nonsurgical medical treatment in the management of pain due to lumbar disc prolapse: A network meta-analysis. in Seminars in arthritis and rheumatism. 2019. Elsevier.
[95]. Park, C.H., et al., Risk Factors for Early Recurrence After Transforaminal Endoscopic Lumbar Disc Decompression. Pain physician, 2019. 22(2): p. E133-E138.
[96]. Huang, J., B. Fan, and J. Liu, Overview of risk factors for failed percutaneous transforaminal endoscopic discectomy in lumbar disc herniation. Zhongguo gu shang= China journal of orthopaedics and traumatology, 2019. 32(2): p. 186-189.
[97]. Dulebohn, S.C., R.N. Massa, and F.B. Mesfin, Disc Herniation. 2019.
[98]. Dindo, D. and P.-A. Clavien, What is a surgical complication? World journal of surgery, 2008. 32(6): p. 939-941.
[99]. Cho, K.-J., et al., Complications in posterior fusion and instrumentation for degenerative lumbar scoliosis. Spine, 2007. 32(20): p. 2232-2237.
[100]. de Waal Malefijt, M.C., An orthopedic complication-registration system. Acta orthopaedica Scandinavica, 1995. 66(1): p. 84-89.
[101]. Clavien, P.A., et al., The Clavien-Dindo classification of surgical complications: five-year experience. Annals of surgery, 2009. 250(2): p. 187-196.
[102]. Ter Gunne, A.F.P. and D.B. Cohen, Incidence, prevalence, and analysis of risk factors for surgical site infection following adult spinal surgery. Spine, 2009. 34(13): p. 1422-1428.
[103]. Reis, R.C., et al., Risk of complications in spine surgery: a prospective study. The open orthopaedics journal, 2015. 9: p. 20.
[104]. Fritzell, P., O. Hägg, and A. Nordwall, Complications in lumbar fusion surgery for chronic low back pain: comparison of three surgical techniques used in a prospective randomized study. A report from the Swedish Lumbar Spine Study Group. European spine journal, 2003. 12(2): p. 178-189.
[105]. Moin, H., P. Mohagheghzadeh, and A. Darbansheikh, The use of frozen autogenous bone flap for cranioplasty. 2005.
[106]. Rish, B.L., et al., Cranioplasty: a review of 1030 cases of penetrating head injury. Neurosurgery, 1979. 4(5): p. 381-385.
[107]. JP, D., Cranial defect & cranioplasty. Clin Neurosurg, 1996(275): p. 2783–2795.
[108]. Andrabi, S.M., et al., Cranioplasty: Indications, procedures, and outcome–An institutional experience. Surgical neurology international, 2017. 8.
[109]. Arques, E., et al., Antibioprophylaxie chirurgicale : une évaluation des pratiques professionnelles. Le Pharmacien Hospitalier, 2007. 42(170): p. p. 135-142.
[110]. Rambourdin, M., et al, Antibioprophylaxie pour césarienne : modification des pratiques et administration avant incision, enquête de faisabilité auprès des pédiatres du réseau de santé périnatale d’Auvergne (RSPA). Annales Françaises d'Anesthésie et de Réanimation, 2013. 32(1): p. p. 12-17.
[111]. Brown, E.M., Antimicrobial prophylaxis in neurosurgery. Journal of Antimicrobial Chemotherapy, 1993. 31: p. 49-63.
[112]. Platt, R., Zaleznik, D. F., Hopkins, C. C, Dellinger, E. P., Karchmer, A. W., Bryan, C. S. et al., Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. New England Journal of Medicine,, 1990. 322: p. 153-60.
[113]. Awatif, R., Evaluation de la pratique de l’antibioprophylaxie en milieu chirurgical (Respect des règles de prescriptions). 2010.
[114]. SFAR, Annales Françaises d’Anesthésie et de Réanimation 2004. 23 p. 1020–1026. [115]. Guodong Li, B., Ke Pu, MD, YiYao Cao, BS, Jun Wang, BS, ZhiMing Sun, MD,
QingGuo Li, MD, The Role of Antibiotic Prophylaxis in Shunt Surgery. World Neurosurgery, 2017. 108: p. 548-554.
[116]. Askarian M, R.M.A., Assadian O., Prescription of prophylactic antibiotics for neurosurgical procedures in teaching hospitals in Iran. American journal of infection control, 2007. 35(4): p. 260-262.
[117]. Ross D, R.H., Pons V., Differentiation of aseptic and bacterial meningitis in postoperative neurosurgical patients. J Neurosurg, 1988. 69(5): p. 669-674.
[118]. F.Salord, O.B., N.Eynard, C.Perret, J.Grando, R.Chacornac, Intérêt du dosage du D(-) lactate pour le diagnostic rapide de méningite après craniotomie. Etude préliminaire. Annales Françaises d'Anesthésie et de Réanimation, 1994. 13(5): p. 647-653.
[119]. BECK-SAGUE CM, J.W., BROOK JH et al. , Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. . American journal of epidemiology, 1990. 132(4): p. 723–733.
[120]. Boyce JM, W.R., Causey WA, Lockwood WR., Burn units as a source of methicillin-resistant Staphylococcus aureus infections. . JAMA, 1983. 249(20): p. 2803-2807.
[121]. BURN-BUISSON C, L.P.A.E.A., Decontamination for control of nosocomial multiresistant gram negative bacilli: Study of an outbreak in intensive care unit. Ann Intern Med, 1989. 110: p. 873-881.
[122]. CASEWELL M, P.E., Hands as a route of transmission of Klebsiella species. Br Med J, 1977. 2: p. 1315-1317.
[123]. Korinek AM, B.T., Golmard JL, van Effenterre R, Coriat P, Puybasset L., Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery, 2008. 62(2): p. 532-539.
[124]. RL., Wright., Post operative craniotomy infections. J. Neurosurg, 1966. 25: p. 125-132. . [125]. GC., Blomstedt., Craniotomy infections. Neurosurg. Clin. North. Am, 1992. 3: p.
[126]. Djindjian, M. Antibioprophylaxie en neurochirurgie. in Annales françaises d'anesthésie et de réanimation. 1994. Elsevier.
[127]. MOEKEL B, H.M., SALVATI EA, PELLICI PM. , Total hip arthroplasty in patients with diabetes mellitus. J. Arthroplasty, 1993. 8: p. 279-284.
[128]. TIRESIAS, Evaluation du risqué infectieux post opératoire. TIRESIAS, 1998: p. 27-34. [129]. Deacon JM, P.A., Zelicof SB, Horowitz HW., Prophylactic use of antibiotics for
procedures after total joint replacement. J Bone Joint Surg Am., 1996. 78(11): p. 1755-1770. [130]. Beyer CA, H.A., Lewallen DG, Pittelkow MR., Primary total knee arthroplasty in
patients with psoriasis. J Bone Joint Surg Br., 1991. 73(2): p. 258-259.
[131]. STEPHENS JL, P.J., Uncommon infections: eye and CNS. . 2nd Williams et willkins, 1993: p. 746-775.
[132]. METHA G, P.B., Computer assisted analysis of wound in neurosurgery. 1988. 11: p. 244-252.
[133]. ZENTNER J, G.J., DASHMER F., Incidence of wound infection in patients undergoing craniotomy: influence of type of shaving. Acta. Neurosurg. Wien., 1987: p. 79-82.
[134]. Ratanalert S, S.S., Sripairojkul B, Liewchanpattana K, Phuenpathom N., Nonshaved cranial neurosurgery. Surg Neurol., 1999. 51(4): p. 458-463.
[135]. Grabsch, E.A., et al., Risk of environmental and healthcare worker contamination with vancomycin-resistant enterococci during outpatient procedures and hemodialysis. Infection Control & Hospital Epidemiology, 2006. 27(3): p. 287-293.
[136]. Boyce, J.M., et al., Environmental contamination due to methicillin-resistant Staphylococcus aureus possible infection control implications. Infection Control & Hospital Epidemiology, 1997. 18(9): p. 622-627.
[137]. NNIS, S., National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. American journal of infection control, 2003. 31(8): p. 481.
[138]. Majjad.A, Evaluation des pratiques de l’antibioprophylaxie et l’impact d’un guideline local.(Respect des régles de prescriptions). 2013.
[139]. Napolitano F, I.M., Di Giuseppe G, Angelillo IF; Collaborative Working Group., Evaluation of the appropriate perioperative antibiotic prophylaxis in Italy. PLoS One., 2013. 8(11): p. e79532.
[140]. J.Lemtiri-Floreka, A.D., M.Delvalléeb, M.-A.Ségarda, P.De Souzac, M.-H.Dubusa, A.Markiewiczd, L.Méteyerc, B.Luyssaerta, Audit des pratiques en antibioprophylaxie chirurgicale dans un centre hospitalier. Le Pharmacien Hospitalier et Clinicien 2014. 49(2): p. 89-94.
[141]. Wen-Dangare.D, O., Étude de l’antibioprophylaxie en chirurgie d’urgences au bloc opératoire des urgences de HMIMV de Rabat. 2017.
[142]. Goede WJ, L.J., Thompson RL, Cima RR., Assessment of prophylactic antibiotic use in patients with surgical site infections. Hosp Pharm, 2013. 48(7): p. 560-567.
[143]. Alotaibi AF, M.R., Zaidi HA, Smith TR, Pandya A., Safety and Efficacy of Antibacterial Prophylaxis After Craniotomy: A Decision Model Analysis. World Neurosurgery, 2017. 106: p. 906-912.
[144]. Dimovska-Gavrilovska A, C.A., Gavrilovski A, Milenkovikj Z., The Importance of Perioperative Prophylaxis with Cefuroxime or Ceftriaxone in the Surgical Site Infections Prevention after Cranial and Spinal Neurosurgical Procedures. Pril (Makedon Akad Nauk Umet Odd Med Nauki), 2017. 38(2): p. 85-97.
[145]. Bassetti, M., et al., Antimicrobial prophylaxis in minor and major surgery. Minerva anestesiologica, 2015. 81(1): p. 76-91.
[146]. Bratzler, D.W., et al., Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Archives of Surgery, 2005. 140(2): p. 174-182.
[147]. Ratilal, B., J. Costa, and C. Sampaio, Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. Journal of Neurosurgery: Pediatrics, 2008. 1(1): p. 48-56.
[148]. Barker, F.G., Efficacy of prophylactic antibiotics against meningitis after craniotomy: a meta-analysis. Neurosurgery, 2007. 60(5): p. 887-894.
[149]. Nishant, K.K.K. and P. Vijayraghavan, Prospective randomized study for antibiotic prophylaxis in spine surgery: choice of drug, dosage, and timing. Asian spine journal, 2013. 7(3): p. 196.
[150]. Haines, S.J., Topical antibiotic prophylaxis in neurosurgery. Neurosurgery, 1982. 11(2): p. 250-253.
[151]. Maguire, W., THE USE OF ANTIBIOTICS, LOCALLY AND SYSTEMICALLY, IN ORTHOPEDIC SURGERY. The Medical journal of Australia, 1964. 2: p. 412.
[152]. Molinari, R.W., O.A. Khera, and W.J. Molinari III, Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1,512 consecutive surgical cases over a 6-year period. European Spine Journal, 2012. 21(4): p. 476-482. [153]. Rathbone, C.R., et al., Effect of various concentrations of antibiotics on osteogenic cell
viability and activity. Journal of Orthopaedic Research, 2011. 29(7): p. 1070-1074.
[154]. Van Kasteren, M., et al., Adherence to local hospital guidelines for surgical antimicrobial prophylaxis: a multicentre audit in Dutch hospitals. Journal of Antimicrobial Chemotherapy, 2003. 51(6): p. 1389-1396.
[155]. Geroulanos, S., et al., Cephalosporins in surgical prophylaxis. Journal of Chemotherapy, 2001. 13(sup4): p. 23-26.
[156]. Mangram, A.J., et al., Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. American journal of infection control, 1999. 27(2): p. 97-132; quiz 133-4; discussion 96.
[157]. Brown, E.M., et al., Spine update: prevention of postoperative infection in patients undergoing spinal surgery. Spine, 2004. 29(8): p. 938-945.
[158]. Levi, A.D., C.A. Dickman, and V.K. Sonntag, Management of postoperative infections after spinal instrumentation. Journal of neurosurgery, 1997. 86(6): p. 975-980.
[159]. Olsen, M.A., et al., Risk factors for surgical site infection following orthopaedic spinal operations. JBJS, 2008. 90(1): p. 62-69.
[160]. Kim, B., et al., Antibiotic microbial prophylaxis for spinal surgery: comparison between 48 and 72-hour AMP protocols. Asian spine journal, 2010. 4(2): p. 71.
[161]. Alemkere, G., Antibiotic usage in surgical prophylaxis: A prospective observational study in the surgical ward of Nekemte referral hospital. PloS one, 2018. 13(9).